Text and Data Mining valid from 2019-05-17
Received: 20 June 2018
Accepted: 21 March 2019
First Online: 17 May 2019
: J.O. has a collaboration with Kite Pharma and is a member of the Scientific Advisory Board of Intellia Therapeutics. J.O is the inventor on the patent WO2015071763 (CTL peptide epitopes and antigen-specific T cells, methods for their discovery, and uses thereof). T.N.S. is a consultant for Adaptive Biotechnologies, AIMM Therapeutics, Allogene Therapeutics, Amgen, Merus, Neon Therapeutics and Scenic Biotech; is a recipient of grant/research support from MSD, Bristol-Myers Squibb and Merck KGaA; is a stockholder in AIMM Therapeutics, Allogene Therapeutics, Merus, Neogene Therapeutics and Neon Therapeutics; and is a venture partner at Third Rock Ventures.